Amnioreduction in Polyhydramnios

ConditionPolyhydramnios

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

AgeNot listed

SponsorAssiut University

About this trial

The aim of this work is to review the indications, procedural complications and outcomes of amnioreduction in pregnancies complicated by polyhydramnios.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women 20- 38 weeks

Patients with polyhydramnios

Disqualifiers

Lethal fetal anomalies

Pre labor rupture of membranes

Placental separation

Chorioamnionitis

Trial population

All pregnant women between 24 to 38 weeks attending Fetal Medicine Unit at Women's health hospital for antenatal care or admitted due to antepartum hemorrhage or for scheduled surgery and meeting the inclusion criteria are counseled to participate in our study after informed consent. sample size will be devided into 2 groups: Group 1 : patients with Amnioreduction Group 2 : patients with conservative management (without amnioreduction)

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

28 Participants

are grouped into 2 trial groups

Group A: Amnioreduction

Group B: Conservative

Trial outcomes

Primary outcomes

Gestational age at delivery

Determine Gestational age at delivery in polyhydramnios patients . Increased age is good.

Time frame

4 months

Rate of PROM

Number of cases developed PROM

Time frame

4 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: